WENTING WEI: Open Payments
NPI 1619575198 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 50 payments from 4 companies in 2025. Trend: 2023 $500 · 2024 $550 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 32 | $446 |
| Alkermes, Inc. | 14 | $207 |
| Neurocrine BioSciences, Inc. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: INVEGA SUSTENNA, ARISTADA, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
